Exosite inhibition of ADAMTS-5 by a glycoconjugated arylsulfonamide

Volume: 11, Issue: 1
Published: Jan 13, 2021
Abstract
ADAMTS-5 is a major protease involved in the turnover of proteoglycans such as aggrecan and versican. Dysregulated aggrecanase activity of ADAMTS-5 has been directly linked to the etiology of osteoarthritis (OA). For this reason, ADAMTS-5 is a pharmaceutical target for the treatment of OA. ADAMTS-5 shares high structural and functional similarities with ADAMTS-4, which makes the design of selective inhibitors particularly challenging. Here we...
Paper Details
Title
Exosite inhibition of ADAMTS-5 by a glycoconjugated arylsulfonamide
Published Date
Jan 13, 2021
Volume
11
Issue
1
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.